Hallervorden-Spatz disease (PKAN)
Related Subjects:
| Dementias
โน๏ธ About
- ๐งฌ Pantothenate kinase-associated neurodegeneration (PKAN), previously known as Hallervorden-Spatz disease, is a rare autosomal recessive neurodegenerative disorder.
- Characterised by progressive extrapyramidal symptoms, intellectual decline, and iron accumulation in the brain.
๐งฌ Aetiology
- ๐งช Caused by mutations in the PANK2 gene, which encodes pantothenate kinase 2, an enzyme essential for coenzyme A biosynthesis.
- โ๏ธ Mutation leads to abnormal lipid metabolism, oxidative stress, and unexplained iron deposition in the basal ganglia.
- ๐ฌ Affects the globus pallidus, substantia nigra, and red nucleus โ leading to pigmentary degeneration.
๐ฉบ Clinical Features
- ๐ Extrapyramidal signs: Rigidity, dystonia, choreoathetosis, tremor.
- โก Pyramidal signs: Spasticity, hyperreflexia, corticospinal tract involvement.
- ๐ง Progressive dementia and intellectual decline.
- ๐ง Typically adolescent onset (but can vary: childhood to adult-onset).
- โณ Life expectancy limited: death often occurs in the 2ndโ3rd decade due to progressive neurological decline.
Differential Diagnosis
- Wilsonโs disease (copper deposition, Kayser-Fleischer rings).
- Huntingtonโs disease (chorea, cognitive decline).
- Juvenile Parkinsonism.
- Other Neurodegeneration with Brain Iron Accumulation (NBIA) disorders (e.g. PLA2G6-associated neurodegeneration).
๐ Investigations
- ๐งฒ MRI Brain: Classic โeye-of-the-tigerโ sign in the globus pallidus (central hyperintensity with surrounding hypointensity on T2-weighted imaging due to iron deposition).
- ๐งช Genetic testing for PANK2 mutations confirms diagnosis.
๐ Management
- ๐ค Primarily supportive and symptomatic.
- ๐ Anticholinergics, baclofen, or botulinum toxin may help dystonia and spasticity.
- ๐ง Levodopa occasionally trialled, but benefit limited.
- ๐ฉบ Deep brain stimulation (DBS) of globus pallidus may improve severe dystonia in selected cases.
- ๐งโโ๏ธ Multidisciplinary care: neurology, physiotherapy, occupational therapy, and speech therapy.
References